NCT00375388View on ClinicalTrials.gov

The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 1998

Study Completion Date

October 31, 2002

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Metformin on top of intensive insulin therapy

Trial Locations (1)

7909 AA

Bethesda General Hospital and Bethesda Diabetes Center, Hoogeveen

Sponsors
All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

LifeScan

INDUSTRY

collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

collaborator

Dupont Merck

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Novo Nordisk A/S

INDUSTRY

lead

Bethesda General Hospital, Hoogeveen

OTHER